FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older

The New York Times - Business:

Though agency advisers had some safety concerns, the Pfizer shot is expected to be available before the winter R.S.V. season.

Author: Christina Jewett

This post first appeared in The New York Times - Business. Read the original article.